Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic evaluation of the voriconazole IV to oral switch
2012-002085-12Phase 4Terminated
- Sponsor
- UZ Leuven
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in mycoses and invasive mycoses, sponsored by UZ Leuven. Primary endpoint: Pharmacokinetics of voriconazole during switch from intravenous to oral administration. Started Apr 2012; status: terminated.
02
Drugs
voriconazole
03
Conditions
mycosesinvasive mycoses
Beyond the preview
Go deeper on 2012-002085-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002085-12.